AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Science, medicine, and decision making.(GUEST EDITORIAL)

OB GYN News

| November 01, 2005 | Wood, Susan F. | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

When physicians advise their patients about medications or medical devices, whether prescription or over the counter (OTC), they rely on the information provided on the product labels and package inserts. They trust that information to be reliable and unbiased.

That labeling and insert information is based on the scientific and clinical data provided to the Food and Drug Administration by pharmaceutical and medical device companies and is evaluated for safety and efficacy by FDA medical and scientific staff. This information has a well-deserved reputation for being based on science.

Decisions to approve or deny a product in the first place--even if controversial--also are based on objective analyses by review staff at several levels within the FDA. The scientific staff there is extremely dedicated to the agency's mission to protect and advance public health and is very well qualified to do the job.

Unfortunately, recent actions--not based on science--taken by FDA leadership have put not only the FDA's reputation at risk but also the health of women and their families, by limiting women's access to an important product.

That product, of course, is the Plan B emergency contraceptive. The recent decision to delay granting over-the-counter status to Plan B has limited once again the ability for a woman to prevent an unintended pregnancy and thus, in many cases, to prevent an abortion.

The decision to deny over-the-counter status until the FDA finished its deliberations was made despite the fact that every level of review within FDA's Center for Drug Evaluation and Research (CDER) and its outside advisory committee recommended approval. Although FDA does not always agree with its outside advisory committees, it is rare that it has disregarded both the advisory committees and the FDA professional staff.

Plan B emergency contraception has now been denied approval for over-the-counter marketing twice. The ...

Related articles from newspapers, magazines, journals, and more
FDA publishes final guidance on voluntary third-party certification....
Magazine article from: The Food Institute Report February 2, 2009 700+ words
FDA published a final guidance document on voluntary...Foods and Feeds (available at http://www.fda.gov/oc/guidance/third); see also...Comments on the guidance may be submitted to FDA at any time. This guidance describes the general...
FDA, SEC link up on false statements to public.
Newspaper article from: Warning Letter Bulletin March 8, 2004 700+ words
Dear Reader, FDA and the Securities and Exchange Com-mission...developed a closer partnership, whereby FDA will provide SEC with information about potential...executives concealed the fact from investors that FDA would not be approving its drug, Erbitux...
FDA holds nutrition roundtable.(WASHINGTON)(Food and Drug...
Magazine article from: The Food Institute Report December 22, 2008 700+ words
On Dec. 12, FDA held a "Nutrition Roundtable Discussion with Stakeholders" to update interested persons about FDA's current nutrition activities. FDA speakers included CENTER FOR FOOD SAFETY AND APPLIED NUTRITION...
FDA Advisory Committees: Process for Recruiting Members and Evaluating...
General Accounting Office Reports & Testimony November 1, 2008 700+ words
...HHS) Food and Drug Administration (FDA) has been criticized about how it recruits...particular meeting. GAO was asked to examine FDA's advisory committee processes. GAO reported on (1) how FDA recruited individuals for membership and...
FDA regulates reprocessed single-use medical devices.
Newspaper article from: Drug Utilization Review June 1, 2001 700+ words
...the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health...letter to all U.S. hospitals regarding the FDA's intention to enforce requirements regarding...against hospitals that do not comply with the FDA's requirements. Although many SUDs are...
FDA Fails to Meet Legal Deadlines, Says Citizens for a Sound Economy
Newspaper article from: U.S. Newswire February 20, 1996 700+ words
...Citizens for a Sound Economy (CSE) says the FDA failed to make the grade in eight of 11 areas...Feb. 21) on legislation to reform the FDA. By scrutinizing the actual review times provided by the FDA and comparing them against statutory requirements...
FDA asks HHS Inspector General to investigate FDA-sponsored clinical trial.
Newspaper article from: Medical Letter on the CDC & FDA April 20, 2003 700+ words
...The U.S. Food and Drug Administration (FDA) has asked the Inspector General of the...concerns involving a clinical trial that FDA itself sponsored. The trial, named "Bone...Army. The principal investigator is an FDA employee, and the coprincipal investigator...
FDA holds first Reportable Food Registry workshop.(WASHINGTON)(Conference news)
Magazine article from: The Food Institute Report August 3, 2009 700+ words
FDA held a workshop on July 23 in College Park...TERMAN BODE MATZ PC. Information released by FDA concerning the Reportable Food Registry, including...Cosmetic Act (FD&C Act), requiring FDA to establish a Reportable Food Registry not...
For more facts and information, see all results

Source: HighBeam Research, Science, medicine, and decision making.(GUEST EDITORIAL)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA